尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Proxy Form for the Extraordinary General Meeting
2023-11-30
Notice of the Extraordinary General Meeting
2023-11-30
(1) Proposed Appointment and Re-election of Directors and Supervisors; and (2) Notice of the Extraordinary General Meeting
2023-11-30
Proposed Appointment and Re-election of Directors and Supervisors
2023-11-17
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023.
2023-11-02
Terms of Reference of the Audit Committee under the Board of Directors
2023-10-27
Overseas Regulatory Announcement-Announcement on Apixaban Tablets Obtained the D
2023-10-18
Announcement Notice of Board Meeting
2023-10-12
Overseas regulatory announcement-Announcement on Febuxostat Obtaining Notificat
2023-10-10
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-10-09
<
...
7
8
9
10
11
12
13
...
>